
This staining image of kidney tissue affected by candidiasis shows the fungus Candida albicans and infiltrating immune cells.
Image Credit: Biswas Laboratory
Scientific Frontline: Extended "At a Glance" Summary: Immune Reprogramming to Treat Candidiasis
The Core Concept: Systemic candidiasis is a severe, opportunistic fungal infection caused by Candida albicans. Recent research demonstrates that reprogramming the metabolic pathways of a host's immune cells offers a viable strategy to clear the infection, circumventing the need for traditional antifungal medications.
Key Distinction/Mechanism: Rather than targeting the fungus directly with antifungal drugs—which increasingly face resistance—this approach strengthens the host's natural defenses. Because Candida albicans aggressively consumes extracellular glucose, local immune cells (neutrophils) are typically starved and rendered ineffective. However, activating the glycogen phosphorylase liver form (PYGL) enzyme allows these neutrophils to mobilize internal glycogen stores, ensuring their survival and ability to destroy the fungus in a nutrient-deprived environment.
Major Frameworks/Components:
- Neutrophils: The primary effector immune cells responsible for mounting a rapid defense and clearing fungal invaders.
- PYGL Enzyme: An enzyme that breaks down intracellular glycogen, providing a crucial alternative energy source for immune cells operating in hostile, glucose-depleted environments.
- Beta-2 Adrenergic Receptor Agonists: Clinically approved medications (such as Albuterol, typically used for asthma) that successfully activate the PYGL enzyme and upregulate antifungal immune functions in models.
- Metabolic Competition: The fundamental biological conflict where host immune cells and invading pathogens compete for limited localized nutrients.





.jpg)






